Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Aura Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Aura Biosciences, Inc.’s stock price such as:

• Aura Biosciences, Inc.’s current stock price and volume
• Why Aura Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for AURA from analysts
• AURA’s stock price momentum as measured by its relative strength

About Aura Biosciences, Inc. (AURA)

Before we jump into Aura Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette–guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is based in Boston, Massachusetts.

Want to learn more about Aura Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Aura Biosciences, Inc..

Aura Biosciences, Inc.’s Stock Price as of Market Close

As of May 08, 2025, 12:46 PM, CST, Aura Biosciences, Inc.’s stock price was $5.790.

Aura Biosciences, Inc. is up 16.5% from its previous closing price of $4.970.

During the last market session, Aura Biosciences, Inc.’s stock traded between $4.950 and $5.820. Currently, there are approximately 49.94 million shares outstanding for Aura Biosciences, Inc..

Aura Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Aura Biosciences, Inc. Stock Price History

Aura Biosciences, Inc.’s (AURA) price is currently down 0.69% so far this month.

During the month of May, Aura Biosciences, Inc.’s stock price has reached a high of $6.290 and a low of $4.940.

Over the last year, Aura Biosciences, Inc. has hit prices as high as $12.378 and as low as $4.840. Year to date, Aura Biosciences, Inc.’s stock is down 29.56%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Aura Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 07, 2025, there were analysts who downgraded Aura Biosciences, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Aura Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Aura Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Aura Biosciences, Inc. (AURA) by visiting AAII Stock Evaluator.

Relative Price Strength of Aura Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 07, 2025, Aura Biosciences, Inc. has a weighted four-quarter relative price strength of -14.60%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how Aura Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Aura Biosciences, Inc. Stock Price: Bottom Line

As of May 8, 2025, Aura Biosciences, Inc.’s stock price is $5.790, which is up 16.5% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Aura Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.